202 related articles for article (PubMed ID: 23020925)
41. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
42. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
Christova T; Mojtahedi G; Hamel PA
Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
[TBL] [Abstract][Full Text] [Related]
43. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation.
Iyengar AS; Miller PJ; Loupe JM; Hollenbach AD
Pigment Cell Melanoma Res; 2014 Sep; 27(5):846-8. PubMed ID: 24903325
[No Abstract] [Full Text] [Related]
45. Pax3 and hippo signaling coordinate melanocyte gene expression in neural crest.
Manderfield LJ; Engleka KA; Aghajanian H; Gupta M; Yang S; Li L; Baggs JE; Hogenesch JB; Olson EN; Epstein JA
Cell Rep; 2014 Dec; 9(5):1885-1895. PubMed ID: 25466249
[TBL] [Abstract][Full Text] [Related]
46. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
[TBL] [Abstract][Full Text] [Related]
47. T-box protein Tbx18 interacts with the paired box protein Pax3 in the development of the paraxial mesoderm.
Farin HF; Mansouri A; Petry M; Kispert A
J Biol Chem; 2008 Sep; 283(37):25372-25380. PubMed ID: 18644785
[TBL] [Abstract][Full Text] [Related]
48. PAX3 and SOX10 activate MET receptor expression in melanoma.
Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
[TBL] [Abstract][Full Text] [Related]
49. Pax3 function is required specifically for inner ear structures with melanogenic fates.
Kim H; Ankamreddy H; Lee DJ; Kong KA; Ko HW; Kim MH; Bok J
Biochem Biophys Res Commun; 2014 Mar; 445(3):608-14. PubMed ID: 24565836
[TBL] [Abstract][Full Text] [Related]
50. UV-mediated regulation of the anti-senescence factor Tbx2.
Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
[TBL] [Abstract][Full Text] [Related]
51. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
52. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Bosserhoff AK; Ellmann L; Kuphal S
Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
[TBL] [Abstract][Full Text] [Related]
53. PAX3 is expressed in human melanomas and contributes to tumor cell survival.
Scholl FA; Kamarashev J; Murmann OV; Geertsen R; Dummer R; Schäfer BW
Cancer Res; 2001 Feb; 61(3):823-6. PubMed ID: 11221862
[TBL] [Abstract][Full Text] [Related]
54. Pax3 functions at a nodal point in melanocyte stem cell differentiation.
Lang D; Lu MM; Huang L; Engleka KA; Zhang M; Chu EY; Lipner S; Skoultchi A; Millar SE; Epstein JA
Nature; 2005 Feb; 433(7028):884-7. PubMed ID: 15729346
[TBL] [Abstract][Full Text] [Related]
55. Pax3 regulates Wnt1 expression via a conserved binding site in the 5' proximal promoter.
Fenby BT; Fotaki V; Mason JO
Biochim Biophys Acta; 2008 Feb; 1779(2):115-21. PubMed ID: 18086577
[TBL] [Abstract][Full Text] [Related]
56. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
57. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
58. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
59. Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2.
Sinha S; Abraham S; Gronostajski RM; Campbell CE
Gene; 2000 Nov; 258(1-2):15-29. PubMed ID: 11111039
[TBL] [Abstract][Full Text] [Related]
60. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.
Tarnowski M; Grymula K; Reca R; Jankowski K; Maksym R; Tarnowska J; Przybylski G; Barr FG; Kucia M; Ratajczak MZ
Mol Cancer Res; 2010 Jan; 8(1):1-14. PubMed ID: 20068066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
